Keywords: turnaround, skyepharma, injectables, unit, sale, 82m, uk

A turnaround for SkyePharma with injectables unit sale for $82M

Article | 15 January 2007

Print This

UK drug development group SkyePharma looks set to alleviate some of its outstanding problems with the sale of its loss-making ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in